<DOC>
	<DOCNO>NCT02236312</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy wrinkle reduction single treatment three different dos botulinum toxin compare placebo , treatment moderate severe glabellar frown line .</brief_summary>
	<brief_title>Safety Efficacy Study Botulinum Toxin Treatment Glabellar Frown Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate Very Severe glabellar line maximum frown assess subject Investigator least Mild glabellar line rest Any previous treatment botulinum toxin Rhytids glabellar region smooth manually spread skin apart Any previous insertion permanent semipermanent material , hyaluronic acid collagen filler glabellar region Any history facial surgery low orbital rim Any plan facial surgery aesthetic procedure study period Ablative skin resurface chemical peel low orbital rim previous 12 month study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>